|
Page 1 of 5 | 12, rue du Vieux-billard 1205 Genève Switzerland | | +41 (22) 379 34 86 | | +41 (79) 535 06 29 | | Contact me | | December 21, 1981 | | Swiss | | Single | | From the 1st of July 2010 |
Work experience 2005-present - Graduate studies on cell signaling in budding yeast with Prof. Robbie Loewith | | TOR and SCH9 signaling pathways regulating ribosome biogenesis | | | University of Geneva, Department of Molecular Biology, Geneva, CH | | | http://www.molbio.unige.ch/loewith/ | | | The Target of Rapamycin Complex 1 (TORC1) is an essential multiprotein complex conserved from yeast to man. Its kinase activity is specifically inhibited by the macrolide antibiotic rapamycin. TORC1 deregulation in man is implicated in various diseases such as cancer, tuberous sclerosis complex and other hamartomatous syndromes. As the signaling pathways that couple TORC1 to its distal readouts are not well understood, we employed a quantitative, label-free mass spectrometry approach to analyze the rapamycin-sensitive phosphoproteome in yeast. This study identified many novel TORC1 effectors and revealed how this complex plays a central role in eukaryote growth control. | | | ∙ 3H-uracil ribosomal RNA metabolic labeling assays ∙ Gene expression assays by quantitative RT-PCR and primer extension assays ∙ Protein-protein interaction assays by co-immunoprecipitation or affinity purification ∙ Quantitative chromatin immunoprecipitation (ChIP) assays of various proteins ∙ Protein overexpression and purification from yeast and bacteria ∙ In vitro kinase assays with purified recombinant protein substrates and peptides ∙ Polysome profiles on sucrose gradients and ribosome purification from yeast cells | | | ∙ Prof. Ruedi Aebersold (ETH Zürich, CH) for label-free quantitative phosphoproteomic screens ∙ Prof. Ann L. Beyer (University of Virginia, VA, USA) for Miller chromatin spreads and electron microscopy analyses. ∙ Prof. James R. Broach (Princeton University, NJ, USA) for transcriptome profiling by DNA microarrays | | | Molecular genetics practical courses (Undergraduate lab course, 10 h / year) | | | Planned on June 30th 2010 | 2005 - 4 month internship in human pathology of the cytoskeleton with Prof. Christine Chaponnier | | HDAC8 as a potential isoform-specific Actin partner. | | | University Medical Center, Department of pathology and immunology, Geneva, CH | | | http://pathology.unige.ch/patim/group-chaponnier.html | | | Actin is expressed in mammals as six isoforms showing different tissue expression patterns. Polymerized α-sm-Actin expression is directly correlated to cellular contractility and its ectopic expression is associated to various human pathologies such as hypertrophic scars. | | | ∙ Study of HDAC8 tissue expression in rats and mice and correlation with Actin isoforms localization ∙ Study of HDAC8 localization by immunofluorescence microscopy upon the specific depolymerization of the α-sm-Actin cytoskeleton ∙ In vitro HDAC8-α-sm-Actin interaction assays upon Actin polymerization | 2004-2005 - 6 month internship in oncology with Prof. Nancy Hynes | | The Wnt signaling pathway in breast cancer cells | | | Friedrich Miescher Institute, Basel, CH | | | http://fmi.ch/html/research/research_groups/growth_control/nancy_hynes/nancy_hynes.html | | | Wnt proteins are small secreted lipid-modified growth factors implicated in various processes throughout mammalian development and adulthood such as cellular differentiation, tissue patterning. Dysregulation of Wnt signaling was shown to be implicated in a wide range of cancers including breast cancer. | | | ∙ FPLC purification of the Wnt inhibitor sFRP1 from medium of 293T cells overexpressing the protein ∙ Development of luciferase reporter assays of Wnt-induced β-catenin activity in breast cancer cell lines (T47D, HC-11) to control sFRP1 activity ∙ Growth assays in breast cancer cell lines (T47D, HC-11, MCF-7, SkBr3) upon treatment with purified sFRP1 | 2003-2004 4 month internship in viral vector biotechnology with Prof. Daniel Kolakofsky | | Construction of human viral vectors for the cystic fibrosis gene (CFTR) | | | University Medical Center, Department of Microbiology, Geneva, CH | | | The Sendaï paramyxovirus infects epithelial cells of the respiratory tract in humans and rodents but is not pathogenic in human adults. The virus ability to induce high levels of expression of genes recombined in its genome in infected cells suggested that it might be a vector of choice for gene therapy against airway epithelium diseases such as cystic fibrosis. | | | ∙ Insertion of the CFTR gene in the Sendaï virus genome ∙ Reconstitution of active viral particles in BSR-T7/5 cells ∙ Amplification of the virus in fertilized chicken eggs | 2003 - 4 month internship in human energetic metabolism with Prof. Jean-Paul Giacobino | | Leptin-mediated regulation of fatty acids metabolism and insulin resistance in mice | | | University Medical Center, Department of Medical Biochemistry, Geneva, CH | | | Leptin is a small peptide hormone mainly produced by white adipose tissues in mammals. Its production is increased by adiposity and antagonized by fasting. Leptin targets specific neurons in the central nervous systems to control both appetite and energy expenditure. Leptin may also signal directly to peripheral organs such as the liver and muscles to modulate fatty acids metabolism in part by regulating the activity of the Acetyl-CoA carboxylase enzyme. | | | ∙ Glucose uptake assays in in vitro L6 myoblast culture models upon insulin stimulation ∙ Acetyl-CoA carboxylase enzymatic assays in mitochondrial subfractions of skeletal muscles in mice ∙ Analysis of Stearoyl-CoA desaturase 1 (target of Leptin) expression in Leptin-treated mice | 2001-2004 - Assistant teacher at De Candolle High School, Geneva | | ∙ Student coaching for applied inorganic/organic chemistry courses ∙ Replacement teacher for theoretical chemistry courses |
|